Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. (Q42166995)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 2003

Language	Label	Description	Also known as
English	Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.	scientific article published on August 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

based on heuristic

inferred from title

Francesca Biagioni

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Giuseppe Battaglia

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Carla L Busceti

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Francesco Fornai

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Valeria Maria Gloria Bruno

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Ferdinando Nicoletti

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Fabrizio Pontarelli

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Antonio Paparelli

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Stefano Ruggieri

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Neuropharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

45

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

155-166

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced injury

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Functional and molecular characterization of metabotropic glutamate receptors expressed in rat striatal cholinergic interneurones

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

The neuroprotective activity of group-II metabotropic glutamate receptors requires new protein synthesis and involves a glial-neuronal signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Effect of metabotropic glutamate receptor activation on receptor-mediated cyclic AMP responses in primary cultures of rat striatal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Opposite influence of the metabotropic glutamate receptor subtypes mGlu3 and -5 on astrocyte proliferation in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Type 2 Metabotropic Glutamate (mGlu) Receptors Tonically Inhibit Transmitter Release in Rat Caudate Nucleus: In Vivo Studies with (2S,1′S,2′S,3′R)‐2‐(2′‐carboxy‐3′‐phenylcyclopropyl)glycine, a New Potent and Selective Antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

The group II metabotropic glutamate receptor agonist, DCG-IV, alleviates akinesia following intranigral or intraventricular administration in the reserpine-treated rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Selective involvement of mGlu1 receptors in corticostriatal LTD.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Activation of striatal group II metabotropic glutamate receptors has a differential effect on dopamine-D1 and -D2 receptor antagonist-induced hypokinesia in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Dopamine/glutamate interactions in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

(S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Impaired preprodynorphin, but not preproenkephalin, mRNA induction in the striatum of mGluR1 mutant mice in response to acute administration of the full dopamine D(1) agonist SKF-82958.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Glutamate cascade to cAMP response element-binding protein phosphorylation in cultured striatal neurons through calcium-coupled group I metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Potentiation of dopamine-induced cAMP formation by group I metabotropic glutamate receptors via protein kinase C in cultured striatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

The metabotropic glutamate receptors: structure and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Distribution and roles of metabotropic glutamate receptors in the basal ganglia motor circuit: implications for treatment of Parkinson's disease and related disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Ionotropic and metabotropic GABA and glutamate receptors in primate basal ganglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Activation of group I mGluRs is necessary for induction of long-term depression at striatal synapses

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Immunohistochemical localization of metabotropic glutamate receptors mGluR1a and mGluR2/3 in the rat basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

DCG-IV but not other group-II metabotropic receptor agonists induces microglial BDNF mRNA expression in the rat striatum. Correlation with neuronal injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Activation of metabotropic glutamate receptor 1 inhibits glutamatergic transmission in the substantia nigra pars reticulata

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2803%2900146-1

7 January 2021

Identifiers

10.1016/S0028-3908(03)00146-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12842121%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42166995&oldid=1565690220"